CHEMOTHERAPY WITH DOCETAXEL, CISPLATIN AND CAPECITABINE (DCX) FOR ADVANCED GASTRIC CANCER

被引：0
|
作者：
Maeda, O. [1 ]
Ando, T. [2 ]
Ishiguro, K. [1 ]
Watanabe, O. [2 ]
Miyahara, R. [2 ]
Funasaka, K. [3 ]
Ando, Y. [4 ]
Goto, H. [2 ,3 ]
机构：
[1] Nagoya Univ, Dept Adv Res Gastroenterol, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[2] Nagoya Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[3] Nagoya Univ Hosp, Dept Endoscopy, Nagoya, Aichi, Japan
[4] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [21] A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer
    Y H Park
    B-Y Ryoo
    S-J Choi
    H-T Kim
    British Journal of Cancer, 2004, 90 : 1329 - 1333
  • [22] Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer
    Oh, SC
    Park, KH
    Choi, IK
    Yoon, SY
    Kim, SJ
    Seo, JH
    Choi, CW
    Kim, BS
    Shin, SW
    Kim, JS
    Kim, YH
    BRITISH JOURNAL OF CANCER, 2005, 92 (05) : 827 - 831
  • [23] Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer
    S C Oh
    K H Park
    I K Choi
    S Y Yoon
    S J Kim
    J H Seo
    C W Choi
    B S Kim
    S W Shin
    J S Kim
    Y H Kim
    British Journal of Cancer, 2005, 92 : 827 - 831
  • [24] Docetaxel, cisplatin, UFT and leucovorin combination chemotherapy in advanced gastric cancer.
    Oh, SC
    Sung, S
    Park, G
    Choi, I
    Seo, JH
    Choi, C
    Kim, B
    Shin, S
    Kim, Y
    Kim, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 371S - 371S
  • [25] Neoadjuvant Docetaxel, Capecitabine and Cisplatin (DXP) in Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer
    Sym, Sun Jin
    Chang, Heung Moon
    Ryu, Min-Hee
    Lee, Jae-Lyun
    Kim, Tae Won
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kang, Yoon-Koo
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (04) : 1024 - 1032
  • [26] A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer
    Yun, Jina
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (05) : 885 - 891
  • [27] Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer
    Kang, Yoon-Koo
    Ryu, Min-Hee
    Yoo, Changhoon
    Chang, Heung-Moon
    Yook, Jeong Hwan
    Oh, Sung Tae
    Kim, Byung Sik
    Kim, Tae Won
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1435 - 1443
  • [28] Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer
    Yoon-Koo Kang
    Min-Hee Ryu
    Changhoon Yoo
    Heung-Moon Chang
    Jeong Hwan Yook
    Sung Tae Oh
    Byung Sik Kim
    Tae Won Kim
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1435 - 1443
  • [29] A phase II study of adjuvant chemotherapy with docetaxel, capecitabine and cisplatin in patients with curatively resected stage IIIband IV advanced gastric cancer
    Kang, M.
    Ryu, M.
    Ryoo, B.
    Kim, C.
    Kang, B.
    Lee, S.
    Chang, H.
    Lee, J.
    Kim, T.
    Kang, Y.
    EJC SUPPLEMENTS, 2009, 7 (02): : 374 - 374
  • [30] Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer
    Di Lauro, Luigi
    Vici, Patrizia
    Belli, Franca
    Tomao, Silverio
    Fattoruso, Silvia Ileana
    Arena, Maria Grazia
    Pizzuti, Laura
    Giannarelli, Diana
    Paoletti, Giancarlo
    Barba, Maddalena
    Sergi, Domenico
    Maugeri-Sacca, Marcello
    GASTRIC CANCER, 2014, 17 (04) : 718 - 724
12345